Antagonists of growth hormone-releasing hormone inhibit growth of androgen-independent prostate cancer through inactivation of ERK and Akt kinases

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

GHRH antagonist causes DNA damage leading to p21 mediated cell cycle arrest and apoptosis in human colon cancer cells

(2011) Florian Hohla et al.   CELL CYCLE

The Raf/MEK/extracellular signal-regulated kinase 1/2 pathway can mediate growth inhibitory and differentiation signaling via androgen receptor downregulation in prostate cancer cells

(2011) Seung-Keun Hong et al.   EXPERIMENTAL CELL RESEARCH

Growth Hormone-Releasing Hormone Antagonists Inhibit Growth of Human Ovarian Cancer

(2011) A. Papadia et al.   HORMONE AND METABOLIC RESEARCH

Characterisation and manipulation of docetaxel resistant prostate cancer cell lines

(2011) Amanda J O'Neill et al.   Molecular Cancer

Antagonists of growth hormone-releasing hormone (GHRH) reduce prostate size in experimental benign prostatic hyperplasia

(2011) Ferenc G. Rick et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Growth hormone-releasing hormone: not only a neurohormone

(2011) Hippokratis Kiaris et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM

Growth hormone-releasing hormone: Extrapituitary effects in physiology and pathology

(2010) Nektarios Barabutis et al.   CELL CYCLE

LHRH antagonist Cetrorelix reduces prostate size and gene expression of proinflammatory cytokines and growth factors in a rat model of benign prostatic hyperplasia

(2010) Ferenc G. Rick et al.   PROSTATE

New Approaches to the Therapy of Various Tumors Based on Peptide Analogues

(2008) A. Schally   HORMONE AND METABOLIC RESEARCH

Design and End Points of Clinical Trials for Patients With Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group

(2008) Howard I. Scher et al.   JOURNAL OF CLINICAL ONCOLOGY

Dose-dependent growth inhibition in vivo of PC-3 prostate cancer with a reduction in tumoral growth factors after therapy with GHRH antagonist MZ-J-7-138

(2008) Elmar Heinrich et al.   PROSTATE

Antagonists of growth-hormone-releasing hormone: an emerging new therapy for cancer

(2007) Andrew V Schally et al.   Nature clinical practice. Endocrinology & metabolism